Literature DB >> 21518244

Variability of pulse wave velocity and mortality in chronic hemodialysis patients.

Serena Torraca1, Maria Luisa Sirico, Pasquale Guastaferro, Luigi Francesco Morrone, Filippo Nigro, Antonietta De Blasio, Paolo Romano, Domenico Russo, Antonio Bellasi, Biagio Di Iorio.   

Abstract

We have already demonstrated that in chronic hemodialysis (HD) patients, the cyclic variations in both hydration status and blood pressure are responsible for changes in pulse wave velocity (PWV). The aim of this study is to verify whether the cyclic variation of PWV influences mortality in dialysis patients. We studied 167 oligoanuric (urinary output <500 mL/day) patients on chronic standard bicarbonate HD for at least 6 months. They performed 3 HD sessions of 4 hours per week. Patients were classified into 3 groups: normal PWV before and after dialysis (LL); high PWV before and normal PWV after dialysis (HL); and high PWV before and after dialysis (HH). The carotid-femoral PWV was measured with an automated system using the foot-to-foot method. Analysis of variance was used to compare the different groups. The outcome event studied was all-cause mortality and cardiovascular mortality. The PWV values observed were LL in 44 patients (26.3%); HL in 53 patients (31.8%); and HH in 70 patients (41.9%). The 3 groups of patients are homogenous for sex, age, and blood pressure. The HH group had a higher prevalence of (P<0.001) ASCVD. It is interesting that the distribution of patients in the 3 groups is correlated with the basal value of PWV. In fact, when the basal measure of PWV is elevated, there is a higher probability that an HD session cannot reduce PWV (<12 ms). A total of 53 patients (31.7%) died during the follow-up of 2 years: 5 patients in the LL group (11.4%); 16 in the HL group (30.2%); and 32 in the HH group (50.7%) (LL vs. HL, P=0.047; LL vs. HH, P<0.00001; HL vs. HH, P=0.034). We evidence for the first time that different behaviors of PWV in dialysis subjects determine differences in mortality.
© 2011 The Authors. Hemodialysis International © 2011 International Society for Hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518244     DOI: 10.1111/j.1542-4758.2011.00545.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  3 in total

1.  A randomized trial of hemodiafiltration and change in cardiovascular parameters.

Authors:  Irina M Mostovaya; Michiel L Bots; Marinus A van den Dorpel; Muriel P C Grooteman; Otto Kamp; Renée Levesque; Piet M Ter Wee; Menso J Nubé; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

2.  Longer interdialytic interval and cause-specific hospitalization in children receiving chronic dialysis.

Authors:  Tamar Springel; Benjamin Laskin; Justine Shults; Ron Keren; Susan Furth
Journal:  Nephrol Dial Transplant       Date:  2013-07-16       Impact factor: 5.992

3.  Arterial function and cardiovascular risk in dialysis.

Authors:  Biagio R Di Iorio; Lucia Di Micco
Journal:  Anatol J Cardiol       Date:  2015-04       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.